AG
JAZZ icon

AmeriFlex Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

AmeriFlex Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Hold
549
– – 0.05% 269
2025
Q4 		$93.3K Buy
549
+545
+13,625% +$83.6K 0.05% 292
2025
Q3 		$527 Buy
+4
New +$480 ﹤0.01% 1035
2025
Q2 		– Sell
-549
Closed -$68.2K – 1181
2025
Q1 		$68.2K Buy
549
+547
+27,350% +$71.4K 0.03% 402
2024
Q4 		$249 Buy
+2
New +$236 ﹤0.01% 1137

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AmeriFlex Group's JAZZ Position: Q1 2026 in Review

AmeriFlex Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 549 shares worth $104K. The position accounts for 0.05% of the portfolio, ranked #269.

AmeriFlex Group first reported a position in JAZZ in Q4 2024 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • AmeriFlex Group held 549 shares of Jazz Pharmaceuticals worth $104K as of Q1 2026.
  • AmeriFlex Group left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up 0.05% of AmeriFlex Group's portfolio in Q1 2026, its #269 holding.
  • AmeriFlex Group first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.